Gout
MONDO:0005393A condition characterized by painful swelling of the joints, which is caused by deposition of urate crystals.
Also known as: chronic gout, tophaceous disease, tophaceous gout, gout, gouty arthropathy
102 clinical trials for this condition and its sub-types, 102 tagged with Gout itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Part of
-
Gout sufferers could ditch doctor visits with new Self-Monitoring app
Disease control OngoingThis study compares two ways of managing gout: a supported self-management approach where patients monitor their own urate levels with a finger-prick test and adjust medication via a smartphone app, versus usual care where a doctor manages treatment. The goal is to see if the sel…
Sponsor: University of Edinburgh • Aim: Disease control
Last updated Sep 17, 2026 00:00 UTC
-
Could a new pill beat the standard for gout? large trial underway
Disease control OngoingThis Phase 3 trial tests whether a new drug, tigulixostat, is better than the standard gout medication febuxostat at lowering uric acid levels in Chinese adults with gout. About 600 participants will take one of the two drugs for 24 weeks, then switch to tigulixostat for another …
Phase 3 • Sponsor: Innovent Biologics Technology Limited (Shanghai R&D Center) • Aim: Disease control
Last updated Sep 03, 2026 00:00 UTC
-
New gout drug shows promise in major trial
Disease control OngoingThis study tests a new medicine called AR882 to see if it can lower uric acid levels in people with gout. About 750 adults with gout will receive either AR882 or a placebo for 12 months. The main goal is to see if AR882 helps more patients reach a safe uric acid level and reduce …
Phase 3 • Sponsor: Arthrosi Therapeutics • Aim: Disease control
Last updated Sep 02, 2026 00:00 UTC
-
New gout pill enters first human tests
Disease control By invitation onlyThis early-stage trial is testing a new oral drug called F-02-2-Na in 69 adults with high uric acid levels, with or without gout. The main goal is to check the drug's safety and how the body processes it at different doses. Participants will receive either the drug or a placebo, …
Phase 1 • Sponsor: Guangdong Hengqin Novagains Biopharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New hope for tough gout: drug combo targets uric acid after other treatments fail
Disease control OngoingThis study tests a new drug called AR882, taken with a standard gout medication (XOI), in 15 people with severe, uncontrolled gout who have already failed uricase therapy. The goal is to see if the combination can lower uric acid levels and shrink painful uric acid crystal deposi…
Phase 2 • Sponsor: Arthrosi Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
Can a chatbot tame gout? new trial puts AI diet coach to the test
Disease control OngoingThis trial tests an AI chatbot called Gout Buddy that gives personalized diet advice to people with gout. 110 participants will either use the chatbot or receive standard care. The goal is to see if the chatbot improves dietary knowledge, eating habits, medication adherence, and …
Sponsor: SingHealth Polyclinics • Aim: Disease control
Last updated Jun 27, 2026 12:31 UTC
-
Gout patients in the south get a new tool: storytelling on a tablet
Disease control OngoingThis study tests whether a culturally tailored storytelling video, shown on a tablet, can help 200 gout patients—especially African Americans in the Southeast—better understand their condition and stick with long-term treatments like medication, diet, and exercise. The goal is to…
Sponsor: University of Alabama at Birmingham • Aim: Disease control
Last updated Jun 27, 2026 12:31 UTC
-
Email your doctor to beat gout: new trial tests remote care
Disease control OngoingThis study tests whether regular email communication between gout patients and their doctors can help lower uric acid levels more effectively than standard care. 204 adults with confirmed gout will either follow usual care or use a secure messaging system to adjust their medicati…
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC
-
Pharmacists take on heart disease: new study tests community-based risk reduction
Disease control OngoingThis study tests whether a pharmacist-led program can help people reduce their risk of heart disease. Over 1,000 adults with conditions like diabetes, high blood pressure, or obesity are taking part. Pharmacists use a step-by-step guide to assess risk and support lifestyle change…
Sponsor: University of Alberta • Aim: Disease control
Last updated Jun 27, 2026 08:08 UTC
-
New injection aimed at easing gout flares enters early human testing
Symptom relief OngoingThis early-stage study tests a single dose of a new antibody injection in 64 people. Part A includes healthy volunteers to check safety, and Part B includes people with an acute gout flare. The main goal is to see if the drug is safe and how the body processes it.
Phase 1 • Sponsor: Innovent Biologics (Suzhou) Co. Ltd. • Aim: Symptom relief
Last updated Jun 27, 2026 12:38 UTC
-
New hope for gout sufferers with kidney problems: safer flare treatment tested
Symptom relief PausedThis study tests if anakinra is better than prednisone for treating gout flares in people with advanced chronic kidney disease or who have had a kidney transplant. Gout causes sudden, severe joint pain. Standard treatments can be risky for these patients. The study measures pain …
Phase 2 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Symptom relief
Last updated Jun 27, 2026 09:01 UTC
-
Do kidney donors face higher gout risk later in life?
Knowledge-focused OngoingThis study looked at whether people who donate a kidney have a higher chance of developing gout later in life compared to similar healthy people who did not donate. Researchers reviewed health records from 50,000 donors and matched non-donors in Canada over many years. The goal i…
Sponsor: London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's • Aim: Knowledge-focused
Last updated Sep 16, 2026 00:00 UTC
-
New blood test could spot autoimmune diseases earlier
Knowledge-focused By invitation onlyThis study will use a special blood test called mass spectrometry to look at immune cells in 500 people with various autoimmune diseases and healthy volunteers. The goal is to find patterns that could help doctors diagnose these conditions sooner. No treatments are being tested; …
Sponsor: Peking University People's Hospital • Aim: Knowledge-focused
Last updated Aug 28, 2026 00:00 UTC
-
New gout Drug's absorption under the microscope: food may change the game
Knowledge-focused OngoingThis early-stage trial is testing a new drug called F-02-2-Na, designed to lower uric acid levels in people with gout or high uric acid. The study will give 12 healthy adults a single dose of the drug, once on an empty stomach and once after a meal, to see if food changes how the…
Phase 1 • Sponsor: Guangdong Hengqin Novagains Biopharmaceutical Co., Ltd. • Aim: Knowledge-focused
Last updated Aug 01, 2026 00:00 UTC
-
AI-Powered ECG could spot dangerous potassium shifts without blood draws
Knowledge-focused CancelledThis study planned to use a machine learning algorithm to estimate blood potassium levels from a single-lead ECG in hospitalized patients. It was designed as a retrospective analysis of existing data from a home hospital program. However, the study was withdrawn before enrolling …
Sponsor: Brigham and Women's Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:00 UTC
-
AI predicts hospital stays, but study never started
Knowledge-focused CancelledThis study aimed to see if a computer could learn to predict how long a patient would stay in a home hospital program. Researchers planned to use data from past patients to train the computer. However, the study was withdrawn before any patients were enrolled, so no results are a…
Sponsor: Brigham and Women's Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:03 UTC
-
Plant protein swap may cut heart & diabetes risk – but how much?
Knowledge-focused OngoingThis study is a review of many smaller trials that looked at what happens when people replace animal protein (like meat, dairy, eggs) with plant protein (like beans, nuts, seeds). The goal is to see if this simple swap can improve blood sugar, cholesterol, blood pressure, weight,…
Sponsor: John Sievenpiper • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:53 UTC
-
Scans may spot gout risk years before first attack
Knowledge-focused OngoingThis study follows 21 people with high uric acid but no gout symptoms for up to 5 years. Researchers use ultrasound and CT scans to look for tiny crystal deposits in joints. The goal is to see if these deposits can predict who will later develop painful gout flares.
Sponsor: Lille Catholic University • Aim: Knowledge-focused
Last updated Jun 26, 2026 16:09 UTC
-
New CT scan reveals how gout treatments melt crystal deposits
Knowledge-focused OngoingThis study follows 50 adults with tophaceous gout who are starting or adjusting urate-lowering therapy. Researchers use a special CT scan (Dual-Energy CT) to measure how much the uric acid crystals in tophi shrink after 6 and 12 months of treatment. They also check whether bone e…
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Jun 26, 2026 15:46 UTC